TAK-062

· Takeda Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-062, covering 2025-08-20 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet [Phase 2]